Skip to main content

Table 1 The clinical characteristics of all patients (n = 551)

From: Prognostic significance of preoperative serum triglycerides and high-density lipoproteins cholesterol in patients with non-small cell lung cancer: a retrospective study

Characteristics Patients
Age(y) 61 (53–68)
Gender
 Male 383 (69.5%)
 Female 168 (30.5%)
Smoking history
 Y 355 (64.4%)
 N 196 (35.6%)
Stage
 I-II 354 (64.2%)
 IIIA 197 (35.8%)
Pathological tumor
classification (pT)
 pT1–2 475 (86.2%)
 pT3–4 76 (13.8%)
Pathological lymph node
stage (pN)
 pN0 298 (54.1%)
 pN1–2 253 (45.9%)
Histological type
 Squamous cell carcinoma 174 (31.6%)
 Adenocarcinoma 329 (59.7%)
 Large cell carcinoma 48 (8.7%)
Surgery type
 Lobectomy 395 (71.7%)
 Pneumonectomy 120 (21.8%)
 Other 36 (6.5%)
Adjuvant chemotherapy
 Y 299 (54.3%)
 N 252 (45.7%)
GLU (mmol/L) 5.27 (4.78–5.88)
TC (mmol/L) 4.20 (3.63–4.89)
TG (mmol/L) 1.09 (0.80–1.72)
HDL-C (mmol/L) 1.17 (0.97–1.40)
LDL-C (mmol/L) 2.55 (2.08–3.08)
ApoA1(g/L) 1.15 (1.01–1.29)
Apo B(g/L) 0.85 (0.71–1.02)
Lpa (mg/L) 189 (90–408)
  1. Continuous variables were shown as median (first-third interquartile range [IQR])
  2. Categorical variables were shown as percentages